Sharepoint Solutions
PRODUCTS
-
Biotech companies progressing through clinical trials, planning an IPO, and undergoing rapid growth have a unique set of financial, contract, compliance, and reporting needs. We have designed an ERP solution, built on NetSuite, to address all of these needs. With over 50 implementations in the last two years alone, SuiteSuccess for Life Sciences is quickly becoming the defacto software standard for all successful biotechnology companies.
-
Referenced in the new USP <1207> Chapter Guidance as a deterministic test method for container closure integrity testing.
-
Shorten start-up times for your clinical research studies by eliminating manual spreadsheets once and for all. SuiteSuccess for contract and clinical research organizations (CROs) allows you to unify clinical applications to improve visibility and oversight across the organization in one software platform. Now you can automate inefficient manual processes, from bid to bill, and deliver more quickly and more profitably than your competitors.
-
Mikart’s development services include a range of pre-formulation capabilities for both oral solid and non-sterile oral liquid dose drug products.
-
TrackWise Manufacturing makes it easier than ever for life sciences manufacturers of all sizes and complexities to achieve outstanding outcomes.
WHITE PAPERS AND CASE STUDIES
-
Predictive Modeling Of Transmitted Wavefront Error In High-Performance Optical Coatings
When interferometric testing isn’t possible, an analytical, spectral-based model predicts coating-contributed transmitted wavefront error with confidence, enabling compliance and control for advanced optical systems.
-
NuGenesis 9.3 – What's New
Explore the latest features of a user-centric lab management system that comprises data, workflow, and sample management capabilities to support the entire product lifecycle.
-
Gene Therapy For Mitochondrial Disease: A Guide To Emerging Regulation
Learn how the FDA's expedited programs, along with the efforts of innovative companies, are paving the way for the development of effective gene therapies to address primary mitochondrial diseases.
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
GMP Calibration Management
Learn why generic EAM systems fall short in regulated industries and how purpose-built solutions ensure compliance, efficiency, and audit readiness.
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.
-
Delivering Value Across Sites With Unified Quality Operations
Standardizing quality processes across 14 sites has enabled faster lead times. Discover how a unified platform reduces complexity, improves compliance, and delivers greater value for customers.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Catalent's Journey Of Continuous Improvement For CSV Excellence
Learn how organizations must continuously reassess validation processes and digital tools to ensure compliance, enhance efficiency, and support global scalability amidst evolving regulatory expectations.
-
Metropolitan Sewer District Of Greater Cincinnati
The Lower Mill Creek Partial Remedy (LMCPR) in Hamilton County, Ohio, is a large, complex effort to remove about 1.78 billion gallons of combined sewer overflows (CSOs) annually from the Mill Creek, an Ohio River tributary. When complete, LMCPR will improve water quality and serve as a catalyst to improve local neighborhoods.
NEWS
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
Partnerships Drive Wheat Production And Livelihoods In Zimbabwe9/3/2025
Phaphamani Irrigation Scheme in Umguza District, Matabeleland North Province, Zimbabwe, yesterday showcased the transformative power of strong partnerships in boosting wheat production and improving rural livelihoods.
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.
-
H2APEX And Copenhagen Infrastructure Partners Enter Into Strategic Partnership For Pioneering Hydrogen Project In Lubmin8/5/2025
H2APEX Group SCA announces that Copenhagen Infrastructure Partners (CIP) – one of the world’s leading investment companies in energy infrastructure investments – has acquired a majority stake of 70% in the first phase of H2APEX’s IPCEI-funded hydrogen project in Lubmin through its Energy Transition Fund (CI ETF I) as a strategic investor.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research2/6/2025
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.